Latest development4 months ago
Apnimed Files for US IPO Amid Biotech Market Revival
The sleep apnea pharmaceutical specialist seeks a U.S. listing to fund late-stage clinical developments as biotech investor appetite returns.
Read the full story
A Nasdaq-listed Korean media company confirmed the liquidation of its entire Bitcoin treasury to pivot toward AI infrastructure and maintain its listing status. Concurrently, the IPO market saw significant activity as Bleichroeder Acquisition Corp. III completed a $345 million offering and Mercator Acquisition Corp. priced its $150 million IPO. Additionally, pharmaceutical firm Apnimed has filed for a U.S. initial public offering to fund the development of its sleep apnea treatment.
The sleep apnea pharmaceutical specialist seeks a U.S. listing to fund late-stage clinical developments as biotech investor appetite returns.
Read the full storyBleichroeder Acquisition III closed a $345 million IPO while Mercator priced its units at $10.00 to raise $150 million for its Nasdaq debut.
A Korean media firm has emptied its Bitcoin holdings to pivot toward AI infrastructure, aiming to stabilize its financial standing and maintain its Nasdaq listing.